| MP:0001260 | increased body weight | "greater than normal average weight " [J:33400] |
Show
Allelic Composition: Arhgap44Gt(RRZ340)Byg/Arhgap44+
Genetic Background: B6.129P2-Arhgap44Gt(RRZ340)Byg
|
| MP:0001262 | decreased body weight | "lower than normal average weight " [J:61295] |
Show
Allelic Composition: Megf8b2b1702.2Clo/Megf8b2b1702.2Clo
Genetic Background: C57BL/6J-Megf8b2b1702.2Clo
|
| MP:0001399 | hyperactivity | "general restlessness or excessive movement; more frequent movement from one place to another" [Stedman s Medical Dictionary:ISBN 0-683-40008-8, J:60409, J:57125] |
Show
Allelic Composition: Arhgap44Gt(RRZ340)Byg/Arhgap44+
Genetic Background: B6.129P2-Arhgap44Gt(RRZ340)Byg
|
| MP:0001402 | hypoactivity | "reduced movement from one place to another" [Stedman s Medical Dictionary , 27th edition:ISBN 0-683-40008-8, csmith:Cynthia L. Smith , Mouse Genome Informatics Curator, J:64289] |
Show
Allelic Composition: Megf8b2b1702.2Clo/Megf8b2b1702.2Clo
Genetic Background: C57BL/6J-Megf8b2b1702.2Clo
|
| MP:0001431 | abnormal eating behavior | "inability to consume or atypical consumption pattern" [Stedman s Medical Dictionary:ISBN 0-683-40008-8, MGI:cls, J:19212] |
Show
Allelic Composition: Megf8b2b1702.2Clo/Megf8b2b1702.2Clo
Genetic Background: C57BL/6J-Megf8b2b1702.2Clo
|
| MP:0001547 | abnormal lipid level | "anomalous concentrations of fat-soluble substances (molecules composed of carbon and hydrogen and are characteristically insoluble in water) in the body" [Stedman s Medical Dictionary:ISBN 0-683-40008-8] |
Show
Allelic Composition: Megf8b2b1702.2Clo/Megf8b2b1702.2Clo
Genetic Background: C57BL/6J-Megf8b2b1702.2Clo
|
| MP:0001783 | decreased white fat amount | "reduced quantity of fat-storing cells/tissue" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Megf8b2b1702.2Clo/Megf8b2b1702.2Clo
Genetic Background: C57BL/6J-Megf8b2b1702.2Clo
|
| MP:0002078 | abnormal glucose homeostasis | "anomaly in the state of equilibrium or processing in the body with respect to glucose in the fluids and tissues" [csmith:Cynthia L. Smith , Mouse Genome Informatics Curator] |
Show
Allelic Composition: Megf8b2b1702.2Clo/Megf8b2b1702.2Clo
Genetic Background: C57BL/6J-Megf8b2b1702.2Clo
|
| MP:0002310 | resistance to fatty liver development | "less likely than the norm to to develop hepatic steatosis " [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Megf8b2b1702.2Clo/Megf8b2b1702.2Clo
Genetic Background: C57BL/6J-Megf8b2b1702.2Clo
|
| MP:0002702 | decreased circulating free fatty acid level | "lower than normal levels of unesterified fatty acids in the blood" [Stedman s Medical Dictionary:ISBN 0-683-40008-8] |
Show
Allelic Composition: Megf8b2b1702.2Clo/Megf8b2b1702.2Clo
Genetic Background: C57BL/6J-Megf8b2b1702.2Clo
|
| MP:0003383 | abnormal gluconeogenesis | "anomaly in the formation of glucose from noncarbohydrates, such as proteins or fat" [J:93896] |
Show
Allelic Composition: Megf8b2b1702.2Clo/Megf8b2b1702.2Clo
Genetic Background: C57BL/6J-Megf8b2b1702.2Clo
|
| MP:0003458 | decreased circulating ketone body level | "less than the normal amount of acetoacetate, 3-hydroxybutyrate and acteone in the blood; produced by fatty acid and carbohydrate metabolism and seen in conditions such as starvation and diabetes mellitus" [Stedman s Medical Dictionary , 27th edition:ISBN 0-683-40008-8] |
Show
Allelic Composition: Megf8b2b1702.2Clo/Megf8b2b1702.2Clo
Genetic Background: C57BL/6J-Megf8b2b1702.2Clo
|
| MP:0003868 | abnormal feces composition | "increase or decrease in the amount of compunds normally found in the feces (fat, protein etc) or presence of material not normally seen in the feces" [smb:Susan M Bello, Mouse Genome Informatics Curator] |
Show
Allelic Composition: Megf8b2b1702.2Clo/Megf8b2b1702.2Clo
Genetic Background: C57BL/6J-Megf8b2b1702.2Clo
|
| MP:0003960 | increased lean body mass | "more than average fat-free physical bulk or volume of the body including all its components except adipose tissue" [honda:Hiraoki Onda, Mouse GEnome Informatics Curator] |
Show
Allelic Composition: Megf8b2b1702.2Clo/Megf8b2b1702.2Clo
Genetic Background: C57BL/6J-Megf8b2b1702.2Clo
Allelic Composition: Acot13tm1Deco/Acot13tm1Deco
Genetic Background: Not Specified
|
| MP:0004889 | increased energy expenditure | "increase in the number of calories used per unit time or decrease in weight gain for a given amount of food eaten" [MGI:smb "Susan M. Bello, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Acot13tm1Deco/Acot13tm1Deco
Genetic Background: Not Specified
|
| MP:0005289 | increased oxygen consumption | "greater than the normal rate at which oxygen enters the blood from alveolar gas; this is equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body" [MeSH:National Library of Medicine - Medical Subject Headings , 2003] |
Show
Allelic Composition: Arhgap44Gt(RRZ340)Byg/Arhgap44+
Genetic Background: B6.129P2-Arhgap44Gt(RRZ340)Byg
|
| MP:0005290 | decreased oxygen consumption | "less than the normal rate at which oxygen enters the blood from alveolar gas; this is equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body" [MeSH:National Library of Medicine - Medical Subject Headings , 2003] |
Show
Allelic Composition: Megf8b2b1702.2Clo/Megf8b2b1702.2Clo
Genetic Background: C57BL/6J-Megf8b2b1702.2Clo
|
| MP:0005292 | improved glucose tolerance | "better than the normal response to oral consumption or intravenous injection of specified amounts of glucose and indicative of insulin sensitivity; measured by determining whole blood or plasma sugar level in a fasting state before and after taking glucose at specified intervals" [MeSH:National Library of Medicine - Medical Subject Headings , 2003] |
Show
Allelic Composition: Megf8b2b1702.2Clo/Megf8b2b1702.2Clo
Genetic Background: C57BL/6J-Megf8b2b1702.2Clo
|
| MP:0005584 | abnormal enzyme/coenzyme activity | "altered ability of any of these proteins, or their cofactors, to act as catalysts to induce chemical changes in other substances" [Stedman s Medical Dictionary:ISBN 0-683-40008-8] |
Show
Allelic Composition: Megf8b2b1702.2Clo/Megf8b2b1702.2Clo
Genetic Background: C57BL/6J-Megf8b2b1702.2Clo
|
| MP:0009125 | decreased brown fat cell lipid droplet size | "reduction in the size of the multiple small droplets of triglycerides found in brown adipocytes" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Acot13tm1Deco/Acot13tm1Deco
Genetic Background: Not Specified
|
| MP:0009289 | decreased epididymal fat pad weight | |
Show
Allelic Composition: Megf8b2b1702.2Clo/Megf8b2b1702.2Clo
Genetic Background: C57BL/6J-Megf8b2b1702.2Clo
|
| MP:0009356 | decreased liver triglyceride level | "lower than normal concentration of triacylglycerols in the liver" [MGI:smb "Susan M. Bello, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Megf8b2b1702.2Clo/Megf8b2b1702.2Clo
Genetic Background: C57BL/6J-Megf8b2b1702.2Clo
|
| MP:0010026 | decreased liver cholesterol level | "less than normal amount in the liver of the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones; it is a component of the plasma membrane lipid bilayer and of plasma lipoproteins and can be found in all animal tissues" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Megf8b2b1702.2Clo/Megf8b2b1702.2Clo
Genetic Background: C57BL/6J-Megf8b2b1702.2Clo
|
| MP:0010378 | increased respiratory quotient | "increase in the ratio of the volume of carbon dioxide released to oxygen consumed by a body tissue or an organism compared to controls" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Acot13tm1Deco/Acot13tm1Deco
Genetic Background: Not Specified
|
| MP:0010379 | decreased respiratory quotient | "reduction in the ratio of the volume of carbon dioxide released to oxygen consumed by a body tissue or an organism compared to controls" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Megf8b2b1702.2Clo/Megf8b2b1702.2Clo
Genetic Background: C57BL/6J-Megf8b2b1702.2Clo
|
| MP:0011016 | increased core body temperature | "increased degree of heat natural to the internal center of a living being" [MGI:smb "Susan M. Bello, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Acot13tm1Deco/Acot13tm1Deco
Genetic Background: Not Specified
|
| MP:0011019 | abnormal adaptive thermogenesis | "anomaly in the regulated production of heat in response to short term environmental changes, such as stress, diet or reduced temperature, often resulting in metabolic inefficiency or death" [PMID:16836744] |
Show
Allelic Composition: Acot13tm1Deco/Acot13tm1Deco
Genetic Background: Not Specified
|
| MP:0011020 | abnormal circadian temperature homeostasis | "any anomaly in the process in which an organism modulates its internal body temperature at different values with a regularity of approximately 24 hours" [GO:0060086] |
Show
Allelic Composition: Acot13tm1Deco/Acot13tm1Deco
Genetic Background: Not Specified
|
| MP:0011939 | increased food intake | "increase in the total number of calories/food amount taken in over time when compared to the normal state" [MGI:csmith] |
Show
Allelic Composition: Acot13tm1Deco/Acot13tm1Deco
Genetic Background: Not Specified
|
| MP:0011940 | decreased food intake | "reduction in the total number of calories/food amount taken in over time when compared to the normal state" [MGI:csmith] |
Show
Allelic Composition: Acot13tm1Deco/Acot13tm1Deco
Genetic Background: Not Specified
|
| MP:0020234 | decreased basal metabolism | "decrease in heat production of an organism at the lowest level of cell chemistry in an inactive, awake, and fasting state" [GOC:NV] |
Show
Allelic Composition: Megf8b2b1702.2Clo/Megf8b2b1702.2Clo
Genetic Background: C57BL/6J-Megf8b2b1702.2Clo
|
